Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Pain signal transmission pathways encompass the neural circuits from peripheral nociceptors to the spinal cord dorsal horn and higher brain centers, involving Aδ and C fibers that detect noxious stimuli like heat, mechanical damage, or chemicals. These pathways process signals through laminae I-II in the dorsal horn, where peptidergic (releasing substance P, CGRP) and non-peptidergic fibers synapse with projection neurons forming the spinothalamic tract, which relays to thalamic nuclei and cortex for localization, intensity, and emotional aspects of pain.[1][3][4] Key molecular players include voltage-gated sodium channels (e.g., Nav1.7), TRP channels (TRPV1), and receptors for prostaglandins, bradykinin, and glutamate, which sensitize during inflammation via second messengers like cAMP/PKA and PKC.[2] Dysregulation contributes to chronic pain in inflammation, neuropathy, and nociplastic conditions, making components like Nav1.7 promising for non-opioid analgesics, though complete blockade risks injury insensitivity.[1][3][6] Drugs target specific nodes, such as CGRP monoclonal antibodies for migraine or opioids for broad inhibition, but challenges include tolerance and side effects.[2][3]
Voltage-gated sodium channel blockade (Nav1.7); TRP channel desensitization (TRPV1); Neurokinin receptor antagonism (NK1); Opioid receptor agonism (mu, delta, kappa); CGRP receptor blockade; GABAergic inhibition
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pain signal transmission pathways.